4.7 Article

Neutrophils homing into the retina trigger pathology in early age-related macular degeneration

期刊

COMMUNICATIONS BIOLOGY
卷 2, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s42003-019-0588-y

关键词

-

资金

  1. National Eye Institute [EY019037-S, EY027691, EY016151, EY 08098]
  2. RPB/IRRF Catalyst Award for Innovative Research Approaches for AMD
  3. F. Hoffmann-La Roche, Ltd., Switzerland
  4. Jennifer Salvitti Davis Chair in Ophthalmology
  5. Robert Bond Welch Chair in Ophthalmology
  6. G. Edward and G. Britton Durell Chair in Ophthalmology
  7. Karl H Hagen Chair in Ophthalmology
  8. Research to Prevent Blindness (Ophthalmology), NY
  9. Research to Prevent Blindness (UPMC), NY
  10. Research to Prevent Blindness (JHMI), NY

向作者/读者索取更多资源

Age-related macular degeneration (AMD) is an expanding problem as longevity increases worldwide. While inflammation clearly contributes to vision loss in AMD, the mechanism remains controversial. Here we show that neutrophils are important in this inflammatory process. In the retinas of both early AMD patients and in a mouse model with an early AMD-like phenotype, we show neutrophil infiltration. Such infiltration was confirmed experimentally using ribbon-scanning confocal microscopy (RSCM) and IFN lambda- activated dye labeled normal neutrophils. With neutrophils lacking lipocalin-2 (LCN-2), infiltration was greatly reduced. Further, increased levels of IFNX in early AMD trigger neutrophil activation and LCN-2 upregulation. LCN-2 promotes inflammation by modulating integrin beta 1 levels to stimulate adhesion and transmigration of activated neutrophils into the retina. We show that in the mouse model, inhibiting AKT2 neutralizes IFN lambda inflammatory signals, reduces LCN-2-mediated neutrophil infiltration, and reverses early AMD-like phenotype changes. Thus, AKT2 inhibitors may have therapeutic potential in early, dry AMD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据